tenk.fyi

VOLITIONRX LTD

VNRXNYSE· In Vitro & In Vivo Diagnostic Substances

Price History

Revenue

$1.2M

59.1% YoY

Net Income

-$27.3M

23.6% YoY

EPS

$-0.31

38.0% YoY

Cash

$3.3M

84.3% YoY

FY 2024 · As of 2024-12-31